ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastroesophageal Reflux Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-32Q8365
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Gastroesophageal Reflux Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Gastroesophageal Reflux Drugs Market Research Report 2025

Code: QYRE-Auto-32Q8365
Report
July 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Cadila Pharmaceuticals
Astrazeneca plc
Jiangsu Aosaikang
Eisai Co Ltd
Pfizer Inc
Altana Pharma
Takeda
NCPC
Luoxin

Gastroesophageal Reflux Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gastroesophageal Reflux Drugs Market

Gastroesophageal Reflux Drugs Market

The global market for Gastroesophageal Reflux Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gastroesophageal Reflux Disease (GERD) is a digestive disorder that occurs when acidic stomach juices, or food and fluids back up from the stomach into the esophagus.GERD affects people of all ages—from infants to older adults. People with asthma are at higher risk of developing GERD.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastroesophageal Reflux Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroesophageal Reflux Drugs.
The Gastroesophageal Reflux Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastroesophageal Reflux Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastroesophageal Reflux Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gastroesophageal Reflux Drugs Market Report

Report Metric Details
Report Name Gastroesophageal Reflux Drugs Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, Cadila Pharmaceuticals, AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda, NCPC, Luoxin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gastroesophageal Reflux Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gastroesophageal Reflux Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Gastroesophageal Reflux Drugs Market report?

Ans: The main players in the Gastroesophageal Reflux Drugs Market are Bayer, Cadila Pharmaceuticals, AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda, NCPC, Luoxin

What are the Application segmentation covered in the Gastroesophageal Reflux Drugs Market report?

Ans: The Applications covered in the Gastroesophageal Reflux Drugs Market report are Hospitals, Ambulatory surgical centers, Specialty clinics, Others

What are the Type segmentation covered in the Gastroesophageal Reflux Drugs Market report?

Ans: The Types covered in the Gastroesophageal Reflux Drugs Market report are Esomeprazole, Lansoprazole, Omeprazole, Rbeprazole, Dexlansoprazole, Others

Recommended Reports

Digestive Diseases Drugs

Drug Industry Overview

Therapeutics & Endoscopy

1 Gastroesophageal Reflux Drugs Market Overview
1.1 Product Definition
1.2 Gastroesophageal Reflux Drugs by Type
1.2.1 Global Gastroesophageal Reflux Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Esomeprazole
1.2.3 Lansoprazole
1.2.4 Omeprazole
1.2.5 Rbeprazole
1.2.6 Dexlansoprazole
1.2.7 Others
1.3 Gastroesophageal Reflux Drugs by Application
1.3.1 Global Gastroesophageal Reflux Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Ambulatory surgical centers
1.3.4 Specialty clinics
1.3.5 Others
1.4 Global Gastroesophageal Reflux Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastroesophageal Reflux Drugs Revenue 2020-2031
1.4.2 Global Gastroesophageal Reflux Drugs Sales 2020-2031
1.4.3 Global Gastroesophageal Reflux Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gastroesophageal Reflux Drugs Market Competition by Manufacturers
2.1 Global Gastroesophageal Reflux Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gastroesophageal Reflux Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gastroesophageal Reflux Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gastroesophageal Reflux Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastroesophageal Reflux Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastroesophageal Reflux Drugs, Product Type & Application
2.7 Global Key Manufacturers of Gastroesophageal Reflux Drugs, Date of Enter into This Industry
2.8 Global Gastroesophageal Reflux Drugs Market Competitive Situation and Trends
2.8.1 Global Gastroesophageal Reflux Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gastroesophageal Reflux Drugs Players Market Share by Revenue
2.8.3 Global Gastroesophageal Reflux Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gastroesophageal Reflux Drugs Market Scenario by Region
3.1 Global Gastroesophageal Reflux Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gastroesophageal Reflux Drugs Sales by Region: 2020-2031
3.2.1 Global Gastroesophageal Reflux Drugs Sales by Region: 2020-2025
3.2.2 Global Gastroesophageal Reflux Drugs Sales by Region: 2026-2031
3.3 Global Gastroesophageal Reflux Drugs Revenue by Region: 2020-2031
3.3.1 Global Gastroesophageal Reflux Drugs Revenue by Region: 2020-2025
3.3.2 Global Gastroesophageal Reflux Drugs Revenue by Region: 2026-2031
3.4 North America Gastroesophageal Reflux Drugs Market Facts & Figures by Country
3.4.1 North America Gastroesophageal Reflux Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gastroesophageal Reflux Drugs Sales by Country (2020-2031)
3.4.3 North America Gastroesophageal Reflux Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gastroesophageal Reflux Drugs Market Facts & Figures by Country
3.5.1 Europe Gastroesophageal Reflux Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gastroesophageal Reflux Drugs Sales by Country (2020-2031)
3.5.3 Europe Gastroesophageal Reflux Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastroesophageal Reflux Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Gastroesophageal Reflux Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gastroesophageal Reflux Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Gastroesophageal Reflux Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gastroesophageal Reflux Drugs Market Facts & Figures by Country
3.7.1 Latin America Gastroesophageal Reflux Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gastroesophageal Reflux Drugs Sales by Country (2020-2031)
3.7.3 Latin America Gastroesophageal Reflux Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastroesophageal Reflux Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastroesophageal Reflux Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gastroesophageal Reflux Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gastroesophageal Reflux Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastroesophageal Reflux Drugs Sales by Type (2020-2031)
4.1.1 Global Gastroesophageal Reflux Drugs Sales by Type (2020-2025)
4.1.2 Global Gastroesophageal Reflux Drugs Sales by Type (2026-2031)
4.1.3 Global Gastroesophageal Reflux Drugs Sales Market Share by Type (2020-2031)
4.2 Global Gastroesophageal Reflux Drugs Revenue by Type (2020-2031)
4.2.1 Global Gastroesophageal Reflux Drugs Revenue by Type (2020-2025)
4.2.2 Global Gastroesophageal Reflux Drugs Revenue by Type (2026-2031)
4.2.3 Global Gastroesophageal Reflux Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Gastroesophageal Reflux Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gastroesophageal Reflux Drugs Sales by Application (2020-2031)
5.1.1 Global Gastroesophageal Reflux Drugs Sales by Application (2020-2025)
5.1.2 Global Gastroesophageal Reflux Drugs Sales by Application (2026-2031)
5.1.3 Global Gastroesophageal Reflux Drugs Sales Market Share by Application (2020-2031)
5.2 Global Gastroesophageal Reflux Drugs Revenue by Application (2020-2031)
5.2.1 Global Gastroesophageal Reflux Drugs Revenue by Application (2020-2025)
5.2.2 Global Gastroesophageal Reflux Drugs Revenue by Application (2026-2031)
5.2.3 Global Gastroesophageal Reflux Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Gastroesophageal Reflux Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Gastroesophageal Reflux Drugs Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Cadila Pharmaceuticals
6.2.1 Cadila Pharmaceuticals Company Information
6.2.2 Cadila Pharmaceuticals Description and Business Overview
6.2.3 Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Product Portfolio
6.2.5 Cadila Pharmaceuticals Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Gastroesophageal Reflux Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Jiangsu Aosaikang
6.4.1 Jiangsu Aosaikang Company Information
6.4.2 Jiangsu Aosaikang Description and Business Overview
6.4.3 Jiangsu Aosaikang Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jiangsu Aosaikang Gastroesophageal Reflux Drugs Product Portfolio
6.4.5 Jiangsu Aosaikang Recent Developments/Updates
6.5 Eisai
6.5.1 Eisai Company Information
6.5.2 Eisai Description and Business Overview
6.5.3 Eisai Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eisai Gastroesophageal Reflux Drugs Product Portfolio
6.5.5 Eisai Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Gastroesophageal Reflux Drugs Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Altana Pharma
6.7.1 Altana Pharma Company Information
6.7.2 Altana Pharma Description and Business Overview
6.7.3 Altana Pharma Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Altana Pharma Gastroesophageal Reflux Drugs Product Portfolio
6.7.5 Altana Pharma Recent Developments/Updates
6.8 Takeda
6.8.1 Takeda Company Information
6.8.2 Takeda Description and Business Overview
6.8.3 Takeda Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Takeda Gastroesophageal Reflux Drugs Product Portfolio
6.8.5 Takeda Recent Developments/Updates
6.9 NCPC
6.9.1 NCPC Company Information
6.9.2 NCPC Description and Business Overview
6.9.3 NCPC Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 NCPC Gastroesophageal Reflux Drugs Product Portfolio
6.9.5 NCPC Recent Developments/Updates
6.10 Luoxin
6.10.1 Luoxin Company Information
6.10.2 Luoxin Description and Business Overview
6.10.3 Luoxin Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Luoxin Gastroesophageal Reflux Drugs Product Portfolio
6.10.5 Luoxin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastroesophageal Reflux Drugs Industry Chain Analysis
7.2 Gastroesophageal Reflux Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastroesophageal Reflux Drugs Production Mode & Process Analysis
7.4 Gastroesophageal Reflux Drugs Sales and Marketing
7.4.1 Gastroesophageal Reflux Drugs Sales Channels
7.4.2 Gastroesophageal Reflux Drugs Distributors
7.5 Gastroesophageal Reflux Drugs Customer Analysis
8 Gastroesophageal Reflux Drugs Market Dynamics
8.1 Gastroesophageal Reflux Drugs Industry Trends
8.2 Gastroesophageal Reflux Drugs Market Drivers
8.3 Gastroesophageal Reflux Drugs Market Challenges
8.4 Gastroesophageal Reflux Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
Cadila Pharmaceuticals
Astrazeneca plc
Jiangsu Aosaikang
Eisai Co Ltd
Pfizer Inc
Altana Pharma
Takeda
NCPC
Luoxin
List of Tables
 Table 1. Global Gastroesophageal Reflux Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gastroesophageal Reflux Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gastroesophageal Reflux Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gastroesophageal Reflux Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Gastroesophageal Reflux Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gastroesophageal Reflux Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gastroesophageal Reflux Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gastroesophageal Reflux Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gastroesophageal Reflux Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gastroesophageal Reflux Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gastroesophageal Reflux Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Gastroesophageal Reflux Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gastroesophageal Reflux Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gastroesophageal Reflux Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gastroesophageal Reflux Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Gastroesophageal Reflux Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Gastroesophageal Reflux Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Gastroesophageal Reflux Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Gastroesophageal Reflux Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gastroesophageal Reflux Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Gastroesophageal Reflux Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gastroesophageal Reflux Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Gastroesophageal Reflux Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gastroesophageal Reflux Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Gastroesophageal Reflux Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Gastroesophageal Reflux Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gastroesophageal Reflux Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gastroesophageal Reflux Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gastroesophageal Reflux Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Gastroesophageal Reflux Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Gastroesophageal Reflux Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gastroesophageal Reflux Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gastroesophageal Reflux Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gastroesophageal Reflux Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Gastroesophageal Reflux Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Gastroesophageal Reflux Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gastroesophageal Reflux Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gastroesophageal Reflux Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gastroesophageal Reflux Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Gastroesophageal Reflux Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Gastroesophageal Reflux Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gastroesophageal Reflux Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gastroesophageal Reflux Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gastroesophageal Reflux Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Gastroesophageal Reflux Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Gastroesophageal Reflux Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gastroesophageal Reflux Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gastroesophageal Reflux Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Gastroesophageal Reflux Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Gastroesophageal Reflux Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Gastroesophageal Reflux Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Gastroesophageal Reflux Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gastroesophageal Reflux Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gastroesophageal Reflux Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Gastroesophageal Reflux Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Gastroesophageal Reflux Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Gastroesophageal Reflux Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Gastroesophageal Reflux Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Gastroesophageal Reflux Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Gastroesophageal Reflux Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Gastroesophageal Reflux Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Gastroesophageal Reflux Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gastroesophageal Reflux Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gastroesophageal Reflux Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Gastroesophageal Reflux Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Gastroesophageal Reflux Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Gastroesophageal Reflux Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer Gastroesophageal Reflux Drugs Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. Cadila Pharmaceuticals Company Information
 Table 76. Cadila Pharmaceuticals Description and Business Overview
 Table 77. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Product
 Table 79. Cadila Pharmaceuticals Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. AstraZeneca Gastroesophageal Reflux Drugs Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. Jiangsu Aosaikang Company Information
 Table 86. Jiangsu Aosaikang Description and Business Overview
 Table 87. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Product
 Table 89. Jiangsu Aosaikang Recent Developments/Updates
 Table 90. Eisai Company Information
 Table 91. Eisai Description and Business Overview
 Table 92. Eisai Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Eisai Gastroesophageal Reflux Drugs Product
 Table 94. Eisai Recent Developments/Updates
 Table 95. Pfizer Company Information
 Table 96. Pfizer Description and Business Overview
 Table 97. Pfizer Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Pfizer Gastroesophageal Reflux Drugs Product
 Table 99. Pfizer Recent Developments/Updates
 Table 100. Altana Pharma Company Information
 Table 101. Altana Pharma Description and Business Overview
 Table 102. Altana Pharma Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Altana Pharma Gastroesophageal Reflux Drugs Product
 Table 104. Altana Pharma Recent Developments/Updates
 Table 105. Takeda Company Information
 Table 106. Takeda Description and Business Overview
 Table 107. Takeda Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Takeda Gastroesophageal Reflux Drugs Product
 Table 109. Takeda Recent Developments/Updates
 Table 110. NCPC Company Information
 Table 111. NCPC Description and Business Overview
 Table 112. NCPC Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. NCPC Gastroesophageal Reflux Drugs Product
 Table 114. NCPC Recent Developments/Updates
 Table 115. Luoxin Company Information
 Table 116. Luoxin Description and Business Overview
 Table 117. Luoxin Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Luoxin Gastroesophageal Reflux Drugs Product
 Table 119. Luoxin Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Gastroesophageal Reflux Drugs Distributors List
 Table 123. Gastroesophageal Reflux Drugs Customers List
 Table 124. Gastroesophageal Reflux Drugs Market Trends
 Table 125. Gastroesophageal Reflux Drugs Market Drivers
 Table 126. Gastroesophageal Reflux Drugs Market Challenges
 Table 127. Gastroesophageal Reflux Drugs Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gastroesophageal Reflux Drugs
 Figure 2. Global Gastroesophageal Reflux Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gastroesophageal Reflux Drugs Market Share by Type: 2024 & 2031
 Figure 4. Esomeprazole Product Picture
 Figure 5. Lansoprazole Product Picture
 Figure 6. Omeprazole Product Picture
 Figure 7. Rbeprazole Product Picture
 Figure 8. Dexlansoprazole Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Gastroesophageal Reflux Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Gastroesophageal Reflux Drugs Market Share by Application: 2024 & 2031
 Figure 12. Hospitals
 Figure 13. Ambulatory surgical centers
 Figure 14. Specialty clinics
 Figure 15. Others
 Figure 16. Global Gastroesophageal Reflux Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Gastroesophageal Reflux Drugs Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Gastroesophageal Reflux Drugs Sales (2020-2031) & (K Units)
 Figure 19. Global Gastroesophageal Reflux Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 20. Gastroesophageal Reflux Drugs Report Years Considered
 Figure 21. Gastroesophageal Reflux Drugs Sales Share by Manufacturers in 2024
 Figure 22. Global Gastroesophageal Reflux Drugs Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Gastroesophageal Reflux Drugs Players: Market Share by Revenue in Gastroesophageal Reflux Drugs in 2024
 Figure 24. Gastroesophageal Reflux Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Gastroesophageal Reflux Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Gastroesophageal Reflux Drugs Sales Market Share by Country (2020-2031)
 Figure 27. North America Gastroesophageal Reflux Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Gastroesophageal Reflux Drugs Sales Market Share by Country (2020-2031)
 Figure 31. Europe Gastroesophageal Reflux Drugs Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Gastroesophageal Reflux Drugs Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Gastroesophageal Reflux Drugs Revenue Market Share by Region (2020-2031)
 Figure 39. China Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Gastroesophageal Reflux Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Gastroesophageal Reflux Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Gastroesophageal Reflux Drugs Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Gastroesophageal Reflux Drugs Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Gastroesophageal Reflux Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Gastroesophageal Reflux Drugs by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Gastroesophageal Reflux Drugs by Type (2020-2031)
 Figure 61. Global Gastroesophageal Reflux Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Gastroesophageal Reflux Drugs by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Gastroesophageal Reflux Drugs by Application (2020-2031)
 Figure 64. Global Gastroesophageal Reflux Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 65. Gastroesophageal Reflux Drugs Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Gastroesophageal Reflux Disease GERD Drugs and Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastroesophageal Reflux Disease Device Market Research Report 2024
Gastroesophageal Reflux Disease GERD Diagnosis Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastroesophageal Reflux Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastro Esophageal Reflux Disease Drug and Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastro Esophageal Reflux Disease GERD Drug Market Research Report 2025
Global Gastroesophageal Reflux Disease Treatment Device Market Insights Forecast to 2030
GERD Drug and Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digestive Drugs Market Insights Forecast to 2030
Nonerosive Reflux Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Barrett s Esophagus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastric Antisecretory Drug Market Insights Forecast to 2030
Comprehensive Medicine for Esophageal Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastric Motility Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Digestive Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Reflux Device Market Research Report 2024
Global Proton Pump Inhibitor Drug Market Research Report 2025
Gastroesophageal Reflux Disease GERD Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Esophageal Cancer Drugs Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions